Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

By Pharmaceutical Processing | June 22, 2009

WuXi PharmaTech Inc., a pharmaceutical, biotechnology, and medical deviceresearch and development outsourcing company with operations in China and theUnited States, has announced that Felix Hsu has been appointed Senior VicePresident of WuXi AppTec U.S. Prior to joining WuXi, Mr. Hsu worked at Medtronic for 14 years inpositions of increasing responsibility. He has broad experience as a productmanager and business leader, serving as Director of Heart Valve WorldwideMarketing; Vice President of Business Excellence; Vice President of CardiacSurgery for Asia Pacific, based in Hong Kong; and Vice President of SupplyChain Integration based in Minneapolis. Prior to working at Medtronic, heserved in product management, sales management, and strategic planning rolesat Abbott Laboratories and as a business manager at Sabratek. In these roles,he was successful in driving revenue growth through effective productmanagement and in implementing strategies to improve operational excellenceand reduce costs. In his new role, Mr. Hsu will be responsible for WuXi’s U.S. business. Asignificant portion of U.S. revenues are derived from serving the medicaldevice industry, where Mr. Hsu has extensive experience. He will report toEdward Hu, Chief Operating Officer, acting Chief Financial Officer, andcurrent head of U.S. operations. “I am very pleased to welcome Felix on board as we continue to strengthenour U.S. management team,” commented Dr. Ge Li, Chairman and Chief ExecutiveOfficer of WuXi PharmaTech. “Our U.S. operations offer a range of testingservices critical to the successful development and regulatory approval of newbiologics and medical devices. We expect our U.S. business will grow underFelix’s leadership.”

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards